Organization typesPublic Company

Products 41 to 50 of 122

Encapso by Solazyme + Encapso
Biotech components: Plant
Business models: B2C
Country of production: USA
Country of distribution: USA + Middle East + Canada
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (3 years ago)
Date last modified: 2019/04/01 16:30 (2 years ago)
Known funding amount: 174,900,000 USD
Funding types: Shareholder Investment
Industry: Industrial
Market status: On the market
Organization type(s): Public Company
Product categories: Chemical
Production process: Closed Production
Source: SynBio Database
Trading symbol: SZYM (NASDAQ)
Value chain stage: Finished Product
Engineered Tilapia by Intrexon
Biotech components: Gene Editing
Business models: B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/12 14:57 (2 years ago)
Date last modified: 2019/09/12 14:59 (2 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Food & Agriculture
Market status: Early Stage Concept
Organization type(s): Public Company
Product categories: Food
Production process: N/A
Source: N/A
Trading symbol: XON (NASDAQ)
Value chain stage: Finished Product
Eradicake Alpha-Amylase by BASF + Verenium
Biotech components: Enzyme
Business models: B2B
Country of production: Switzerland
Country of distribution: USA + Mexico + Canada + Germany + Singapore + Brazil + China
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (3 years ago)
Date last modified: 2018/12/26 15:23 (3 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Industrial
Market status: On the market
Organization type(s): Public Company
Product categories: Chemical
Production process: Closed Production
Source: SynBio Database
Trading symbol: BAS (ETR)
Value chain stage: Input
EveNootkatone by Evolva
Biotech components: Plant
Business models: B2B
Country of production: Switzerland
Country of distribution: USA + Europe
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (3 years ago)
Date last modified: 2018/08/30 11:49 (3 years ago)
Known funding amount: 86,000,000 CHF
Funding types: Shareholder Investment
Industry: Food & Agriculture
Market status: On the market
Organization type(s): Public Company
Product categories: Additive
Production process: Closed Production
Source: SynBio Database
Trading symbol: EVE (SWX)
Value chain stage: Input
Farnesene by Amyris
Biotech components: Fungus
Business models: B2B
Country of production: USA
Country of distribution: USA
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (3 years ago)
Date last modified: 2018/08/30 11:49 (3 years ago)
Known funding amount: 471,900,000 USD
Funding types: Shareholder Investment
Industry: Industrial
Market status: On the market
Organization type(s): Public Company
Product categories: Chemical
Production process: Closed Production
Source: SynBio Database
Trading symbol: AMRS (NASDAQ)
Value chain stage: Input
fiberTyping by Applied DNA Sciences
Biotech components: Molecule
Business models: B2C
Country of production: USA
Country of distribution: USA
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (3 years ago)
Date last modified: 2019/01/30 11:57 (3 years ago)
Known funding amount: 19,800,000 USD
Funding types: Shareholder Investment
Industry: Security
Market status: Under Development
Organization type(s): Public Company
Product categories: Forensic Tagging
Production process: Closed Production
Source: NASEM Database
Trading symbol: APDN (NASDAQ)
Value chain stage: Finished Product
Biotech components: Gene Editing + Plant
Business models: B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/12 14:47 (2 years ago)
Date last modified: 2019/09/12 14:47 (2 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Food & Agriculture + Novelty
Market status: Early Stage Concept
Organization type(s): Public Company
Product categories: Plant
Production process: N/A
Source: N/A
Trading symbol: XON (NASDAQ)
Value chain stage: Finished Product
Biotech components: Animal + Gene Editing
Business models: B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2020/02/10 09:59 (2 years ago)
Date last modified: 2020/02/10 09:59 (2 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Health
Market status: Under Development
Organization type(s): Public Company
Product categories: N/A
Production process: N/A
Source: Web search
Trading symbol: XON (NASDAQ)
Value chain stage: Finished Product
Biotech components: Enzyme
Business models: B2B
Country of production: Switzerland
Country of distribution: N/A
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (3 years ago)
Date last modified: 2019/05/15 15:45 (2 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Industrial
Market status: On the market
Organization type(s): Public Company
Product categories: Fuel and Energy
Production process: Open Release
Source: Web search
Trading symbol: BAS (ETR)
Value chain stage: Input
Fuelzyme 650 Alpha-amylase by BASF + Verenium
Biotech components: Enzyme
Business models: B2B
Country of production: Switzerland
Country of distribution: USA + Europe + Asia
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (3 years ago)
Date last modified: 2019/05/15 15:45 (2 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Industrial
Market status: On the market
Organization type(s): Public Company
Product categories: Fuel and Energy
Production process: Closed Production
Source: SynBio Database
Trading symbol: BAS (ETR)
Value chain stage: Input